The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorman Broadb Regulatory News (NBB)

Share Price Information for Norman Broadb (NBB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.25
Bid: 8.50
Ask: 10.00
Change: 0.00 (0.00%)
Spread: 1.50 (17.647%)
Open: 9.25
High: 9.25
Low: 9.25
Prev. Close: 9.25
NBB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FY2021 Trading Update

2 Mar 2022 07:00

RNS Number : 2437D
Norman Broadbent PLC
02 March 2022
 

Norman Broadbent plc

("Norman Broadbent", "NBB" or the "Group")

FY2021 Trading Update

Norman Broadbent (AIM: NBB) - a leading London quoted Executive Search and Interim Management firm offering a diversified portfolio of integrated Leadership Acquisition & Advisory Services - provides the following unaudited trading update relating to the twelve months ended 31 December 2021.

The Board is pleased to provide the following update:

Highlights and Financial Information:

· Change in senior leadership team and Board appointments during H2. 

· New strategic plan in place focussed on accelerated, sustainable and profitable growth through acquisition and development of quality fee earning talent in the UK and internationally, combined with greater concentration on high margin Board and Executive Search business and a continually expanding Interim contractor book.

· Group Net Fee Income decreased slightly year-on-year by 5% to £5.9m (2020: £6.2m). However, following a challenging Q3, Q4 showed a very positive recovery as leadership changes and a renewed focus across the Group began to yield results, with £1.8m NFI, a 20% improvement on prior year Q4 (2020: £1.5m) and 38% increase on Q1 to Q3 average of £1.3m.

· Gross margin % increased to 89% (2020: 79%).

· Break even EBITDA for FY2021 (before exceptional restructuring costs).

· Continued selective overhead reductions combined with restructuring of the Senior Leadership and Leadership Consulting team, has reduced cash break-even point further prior to the recruitment of additional high quality and profit generating fee-earning talent.

· Q4 share issue by way of a subscription from major shareholders and senior leadership team raised circa £370k at a premium to support strategic restructuring.

· 2021 audit work commenced - Group anticipates releasing the full results for FY2021 in April 2022.

· 2022 hiring and growth strategy in execution phase. In 2022, to date 5 new fee earners have been secured with considerable further opportunities identified.

Kevin Davidson, Group CEO of Norman Broadbent, commented:

"Having joined Norman Broadbent in September 2021, I have been incredibly impressed with the quality of the team and the shared commitment to our refreshed culture and exciting vision for the Group. This is demonstrated by a significant bounce back from a challenging Q3 (2021) to a very impressive and profitable Q4 performance. The momentum has continued into 2022 and, as our recruitment activities begin to yield results, we look forward to considerably strengthening and building the team in 2022 whilst also delivering positive EBITDA.

My optimism for the Group continues to grow. The quality of the established team, the work we have done over the past few months in refocussing the business, the standard and volume of new hires coming on board, the positive conditions prevailing across our diverse market sectors and the enduring strength of the Norman Broadbent brand all coalesce to create a very positive outlook. 

I am very enthusiastic about the future and would like to thank the team for their commitment to shaping and delivering positive change and delivering exceptional client outcomes. I would also like to thank all our clients (past, present and future) and our ever-supportive shareholders."

Peter Searle, Group Chair of Norman Broadbent, added:

"I am incredibly pleased that we are ahead of our strategic turnaround plan and that the business has continued to trade strongly after an excellent fourth quarter. We have a very capable management team in place who are now adding significant value to the Group."

Steve Smith, Group CFO/COO of Norman Broadbent, said

"It has been a pleasure to work alongside Peter and Kevin as they continue to inject a new level of strategic and operational expertise into the Group. In particular in the second half on 2021, we were able to reposition the business through leadership change and restructuring. We are now poised to accelerate growth in 2022 and beyond with a secure team and the renewed ability to attract and hire new fee earning talent of the highest quality. We continue to benefit from strong banking arrangements in place combined with supportive shareholders.

Looking ahead, we continue to seek growth opportunities and are actively pursuing M&A opportunities, long-term partnerships, and strategic 'tuck-ins'." 

 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

For further information please contact:

Norman Broadbent plc

Kevin Davidson

Peter Searle

Steve Smith

 

+44 (0) 20 7484 0000

 

WH Ireland Limited

Jessica Cave

Darshan Patel

 

+44 (0) 20 7220 1666

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUASSRUAUORAR
Date   Source Headline
20th May 20225:49 pmRNSIssue of Convertible Loan Notes
11th May 20224:16 pmRNSDirector resignation
18th Mar 20227:00 amRNSGrant of Options to Directors and Employees
2nd Mar 20227:00 amRNSFY2021 Trading Update
7th Feb 20227:00 amRNSBoard Changes
7th Dec 20213:50 pmRNSHolding(s) in Company
6th Dec 202110:18 amRNSSubscription
2nd Dec 20217:00 amRNSHolding(s) in Company
12th Nov 20212:30 pmRNSDirector/PDMR Shareholding
1st Nov 20217:00 amRNSAppointment of Group Managing Director
27th Sep 20217:02 amRNSSubscription Results and PDMR Dealing
27th Sep 20217:00 amRNSInterim Results for Six Months Ended 30 June 2021
12th Aug 20217:00 amRNSBoard Changes
12th Jul 20217:00 amRNSBoard Changes
25th Jun 202112:30 pmRNSResult of AGM
15th Jun 20217:00 amRNSAppointment of Executive Chairman
24th May 20217:00 amRNSFinal Results and Annual Accounts
13th May 202111:59 amRNSHolding(s) in Company
12th May 202112:17 pmRNSHolding(s) in Company
12th May 20219:39 amRNSHolding(s) in Company
19th Apr 202111:59 amRNSNotice of Results
19th Apr 202111:53 amRNSHolding(s) in Company
25th Jan 20217:00 amRNSFY2020 Trading Update
26th Nov 20207:00 amRNSFunding Update
23rd Nov 20204:54 pmRNSHolding(s) in Company
21st Oct 20201:45 pmRNSAppointments - Group Managing Director & Others
16th Oct 20201:00 pmRNSDirector/PDMR Shareholding & Concert Party Update
5th Oct 20203:01 pmRNSIssue of Equity
5th Oct 20207:00 amRNSAcquisition of minority interest in NBIMv
28th Sep 20207:00 amRNSInterim Results
27th Aug 202010:40 amRNSDirectorate Change
24th Aug 202010:59 amRNSDirector/PDMR Shareholding
28th Jul 202010:18 amRNSResult of AGM and Appointment of Chair
28th Jul 20207:00 amRNSAGM Statement and Trading Update
16th Jul 202010:35 amRNSHolding(s) in Company
29th Jun 20207:00 amRNSFinal Results and Annual Accounts
26th May 202011:32 amRNSDirector/PDMR Shareholding
18th May 202012:33 pmRNSDirector/PDMR Shareholding
18th May 20207:00 amRNSTrading Update
11th Mar 202012:00 pmRNSAppointment of CFO & COO
9th Mar 20207:00 amRNSChange of address
3rd Mar 20207:00 amRNSExpansion driven by increased client demand
28th Feb 20207:00 amRNSUpdate: Chief Financial Officer Succession
24th Jan 20207:00 amRNSTrading Update
10th Dec 20197:00 amRNSNorman Broadbent Group partners with UN Women UK
26th Sep 20197:00 amRNSInterim Results for six months ended 30 June 2019
9th Sep 20197:00 amRNSNew and Enhanced Working Capital Facility
23rd Aug 201911:31 amRNSHolding(s) in Company
23rd Aug 201910:51 amRNSShareholder Update and Director/PDMR Shareholding
6th Aug 20194:17 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.